MYSM1 Activators
The chemical class termed MYSM1 Activators includes compounds that can potentially modulate the activity or expression of MYSM1 through indirect mechanisms related to chromatin remodeling and transcriptional regulation. These chemicals primarily act as inhibitors of enzymes involved in epigenetic modifications, such as DNA methyltransferases and histone deacetylases. Compounds like 5-Azacytidine, RG108, Sodium Butyrate, and Nicotinamide alter the epigenetic landscape, potentially impacting the function of MYSM1 in chromatin remodeling.
Furthermore, S-Adenosylmethionine, a methyl group donor, and BIX-01294, a G9a inhibitor, can influence histone methylation, indirectly affecting MYSM1's role in transcriptional regulation. Panobinostat and Decitabine, both influencing histone acetylation and DNA methylation, respectively, are also potential indirect modulators of MYSM1. These compounds, by altering the chromatin structure and transcriptional landscape, create a cellular context that can lead to the modulation of MYSM1's activity, reflecting the intricate connection between epigenetic modifications and gene expression regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, altering epigenetic marks and potentially affecting chromatin structure. This can influence MYSM1 function indirectly by changing the transcriptional landscape in which MYSM1 operates. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A DNA methyltransferase inhibitor, which can alter DNA methylation patterns and potentially affect MYSM1 function by modulating the epigenetic state of genes. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A short-chain fatty acid and histone deacetylase inhibitor, which can impact chromatin structure and gene expression, potentially influencing MYSM1 activity. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
A form of vitamin B3 that acts as a sirtuin inhibitor, potentially affecting chromatin structure and gene expression, thereby indirectly influencing MYSM1. | ||||||
Ademetionine | 29908-03-0 | sc-278677 sc-278677A | 100 mg 1 g | $184.00 $668.00 | 2 | |
A common cosubstrate involved in methyl group transfers, which can influence DNA and histone methylation, potentially affecting MYSM1 function indirectly by altering epigenetic states. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
A histone deacetylase inhibitor, which can change chromatin structure and potentially impact MYSM1 function by modulating gene expression patterns. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A potent histone deacetylase inhibitor, affecting chromatin structure and transcription, potentially influencing MYSM1 indirectly. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
A G9a histone methyltransferase inhibitor, which can alter histone methylation and potentially impact MYSM1 activity by changing the epigenetic landscape. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor, similar in function to 5-Azacytidine, potentially impacting MYSM1 function by altering DNA methylation and chromatin structure. | ||||||